28.07.21|Sophie ShulmanSynthetic biology seemed like science fiction until the arrival of the coronavirus vaccines. But now the money has begun to flow and companies are revealing remarkable inventions: from bacteria that will attack tumors to shoes made of cobwebs
10.05.19|Dov GreenbaumFrom racehorse breeding to human medicine, CRISPR gene editing is the future. Researchers worldwide are racing for the patent
30.11.18|Meitar Bilu and Dov GreenbaumEarlier this week, a researcher announced the successful impregnation of a woman and birth of twin baby girls carrying CRISPR altered genomes, sparking global controversy
30.01.18|Lilach BaumerAlready listed on the Tel Aviv Stock Exchange, the Israel-based company is listing on Nasdaq as part of its September investment agreement with Lichtenstein-based Alpha Capital Anstalt
More stories in CTech
